Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Mithra Pharmaceuticals Normalized PE Ratio
Normalized PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Normalized PE Ratio Data
| Date | Value |
|---|---|
| November 19, 2020 | -- |
| November 18, 2020 | -- |
| November 17, 2020 | -- |
| November 16, 2020 | -- |
| November 13, 2020 | -- |
| November 12, 2020 | -- |
| November 11, 2020 | -- |
| November 10, 2020 | -- |
| Date | Value |
|---|---|
| November 09, 2020 | -- |
| November 06, 2020 | -- |
| November 05, 2020 | -- |
| November 04, 2020 | -- |
| November 03, 2020 | -- |
| November 02, 2020 | -- |
| October 30, 2020 | -- |
| October 29, 2020 | -- |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
Normalized PE Ratio Range, Past 5 Years
Normalized PE Ratio Benchmarks
| Galapagos NV | -- |
| UCB SA | Upgrade |
| Nyxoah SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | -- |